82
Views
10
CrossRef citations to date
0
Altmetric
Original Research

Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer

, , , , , & show all
Pages 4485-4494 | Published online: 19 Sep 2014

References

  • NayakLLeeEQWenPYEpidemiology of brain metastasesCurr Oncol Rep2012141485422012633
  • Barnholtz-SloanJSYuCSloanAEA nomogram for individualized estimation of survival among patients with brain metastasisNeuro Oncol201214791091822544733
  • SperdutoPWChaoSTSneedPKDiagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patientsInt J Radiat Oncol Biol Phys201077365566119942357
  • SoffiettiRRudaRTrevisanEBrain metastases: current management and new developmentsCurr Opin Oncol200820667668418841050
  • GabathulerRBlood–brain barrier transport of drugs for the treatment of brain diseasesCNS Neurol Disord Drug Targets20098319520419601817
  • PeereboomDMChemotherapy in brain metastasesNeurosurgery2005575 SupplS54S65 discusssion S51–S5416237290
  • DeekenJFLoscherWThe blood–brain barrier and cancer: transporters, treatment, and Trojan horsesClin Cancer Res20071361663167417363519
  • GerstnerERFineRLIncreased permeability of the blood–brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigmJ Clin Oncol200725162306231217538177
  • HasegawaHUshioYHayakawaTYamadaKMogamiHChanges of the blood–brain barrier in experimental metastatic brain tumorsJ Neurosurg19835923043106864299
  • LockmanPRMittapalliRKTaskarKSHeterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancerClin Cancer Res201016235664567820829328
  • IsselsRDLindnerLHVerweijJEuropean Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)European Society for Hyperthermic Oncology (ESHO)Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre studyLancet Oncol201011656157020434400
  • van der ZeeJGonzalez GonzalezDvan RhoonGCvan DijkJDvan PuttenWLHartAAComparison of radiotherapy alone with radiotherapy plus hyperthermia in locally advanced pelvic tumours: a prospective, randomised, multicentre trialLancet200035592101119112510791373
  • SongCWEffect of local hyperthermia on blood flow and microenvironment: a reviewCancer Res19844410 Suppl4721s4730s6467226
  • SongCWParkHJLeeCKGriffinRImplications of increased tumor blood flow and oxygenation caused by mild temperature hyperthermia in tumor treatmentInt J Hyperthermia200521876176716338859
  • KongGAnyarambhatlaGPetrosWPEfficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug releaseCancer Res200060246950695711156395
  • GasselhuberADreherMRPartanenATargeted drug delivery by high intensity focused ultrasound mediated hyperthermia combined with temperature-sensitive liposomes: computational modelling and preliminary in vivovalidationInt J Hyperthermia201228433734822621735
  • PartanenAYarmolenkoPSViitalaAMild hyperthermia with magnetic resonance-guided high-intensity focused ultrasound for applications in drug deliveryInt J Hyperthermia201228432033622621734
  • MayerLDDoughertyGHarasymTOBallyMBThe role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumorsJ Pharmacol Exp Ther19972803140614149067330
  • GabizonAShmeedaHBarenholzYPharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studiesClin Pharmacokinet200342541943612739982
  • HongRLHuangCJTsengYLDirect comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?Clin Cancer Res19995113645365210589782
  • KongGDewhirstMWHyperthermia and liposomesInt J Hyperthermia199915534537010519688
  • KongGBraunRDDewhirstMWCharacterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculatureCancer Res20016173027303211306483
  • MaedaHMacromolecular therapeutics in cancer treatment: the EPR effect and beyondJ Control Release2012164213814422595146
  • Pinzon-DazaMLCampiaIKopeckaJGarzonRGhigoDRigantiCNanoparticle- and liposome-carried drugs: new strategies for active targeting and drug delivery across blood–brain barrierCurr Drug Metab201314662564023869808
  • FrenkelVEtheringtonAGreeneMDelivery of liposomal doxorubicin (Doxil) in a breast cancer tumor model: investigation of potential enhancement by pulsed-high intensity focused ultrasound exposureAcad Radiol200613446947916554227
  • LinCYTsengHCShiuHRWuMFChouCYLinWLUltrasound sonication with microbubbles disrupts blood vessels and enhances tumor treatments of anticancer nanodrugInt J Nanomedicine201272143215222619550
  • ChenDSunKMuHpH and temperature dual-sensitive liposome gel based on novel cleavable mPEG-Hz-CHEMS polymeric vaginal delivery systemInt J Nanomedicine201272621263022679372
  • LiLten HagenTLHaeriAA novel two-step mild hyperthermia for advanced liposomal chemotherapyJ Control Release201417420220824269966
  • LiLten HagenTLHossannMMild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacyJ Control Release2013168214215023524188
  • YangYYangYXieXPEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapyBiomaterials201435144368438124565519
  • LiuHLHuaMYYangHWMagnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brainProc Nat Acad Sci U S A2010107341520515210
  • ParkEJZhangYZVykhodtsevaNMcDannoldNUltrasound-mediated blood–brain/blood–tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis modelJ Control Release2012163327728423000189
  • TreatLHMcDannoldNZhangYVykhodtsevaNHynynenKImproved anti-tumor effect of liposomal doxorubicin after targeted blood–brain barrier disruption by MRI-guided focused ultrasound in rat gliomaUltrasound Med Biol201238101716172522818878
  • YangFYWongTTTengMCFocused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiformeJ Control Release2012160365265822405901
  • ParkJZhangYVykhodtsevaNJoleszFAMcDannoldNJThe kinetics of blood–brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasoundJ Control Release2012162113414222709590
  • KovacsZWernerBRassiASassJOMartin-FioriEBernasconiMProlonged survival upon ultrasound-enhanced doxorubicin delivery in two syngenic glioblastoma mouse modelsJ Control Release2014187C748224878186
  • HynynenKMcDannoldNSheikovNAJoleszFAVykhodtsevaNLocal and reversible blood–brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonicationsNeuroImage2005241122015588592
  • LiuHLWaiYYChenWSHemorrhage detection during focused-ultrasound induced blood–brain barrier opening by using susceptibility-weighted magnetic resonance imagingUltrasound Med Biol200834459860618313204
  • McDannoldNVykhodtsevaNRaymondSJoleszFAHynynenKMRI-guided targeted blood–brain barrier disruption with focused ultrasound: histological findings in rabbitsUltrasound Med Biol200531111527153716286030
  • McDannoldNVykhodtsevaNJoleszFAHynynenKMRI investigation of the threshold for thermally induced blood–brain barrier disruption and brain tissue damage in the rabbit brainMagn Reson Med200451591392315122673
  • LyassOUzielyBBen-YosefRCorrelation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinomaCancer20008951037104710964334
  • Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug AdministrationGuidance for Industry: Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy VolunteersRockville, MDCenter for Drug Evaluation and Research, Food and Drug Administration2005
  • HurleyLHDNA and its associated processes as targets for cancer therapyNat Rev Cancer20022318820011990855
  • AkiyoshiTWadaTArinagaSKobaFTsujiHEnhanced chemosensitivity of cells from malignant effusions under condition of exposure to high temperatureJpn J Surg19861653233293099042
  • CrowderKCHughesMSMarshJNSonic activation of molecularly-targeted nanoparticles accelerates transmembrane lipid delivery to cancer cells through contact-mediated mechanisms: implications for enhanced local drug deliveryUltrasound Med Biol200531121693170016344131
  • MohanPRapoportNDoxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear traffickingMol Pharm2010761959197320957997